About 1 result found for searched term "PF-06835919" (0.138 seconds)
Cat.No. | Name | Target |
---|---|---|
M21287 | PF-06835919 | Ketohexokinase |
Ketohexokinase inhibitor 1 | ||
PF-06835919 is an oral Class I clinical candidate for NAFLD/NASH, targeting ketohexokinase (KHK), an enzyme that initiates fructose metabolism. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.